Cloning and Sequencing Hybridoma

The National Institute of Allergy and Infectious Diseases (NIAID) intends to procure from Syd Labs the following: Cloning and sequencing mouse IgG Hybridoma (7 each) antibody heavy and light chain variable regions, Amplified DNA fragments; Cloning and sequencing mouse IgM Hybridoma (3 each) antibody heavy and light chain variable regions, Amplified DNA fragments. This will be a firm fixed price contract in accordance with the statutory authority for this sole source requirement 41 U.S.C. 3304 (c) (1) as implemented by FAR 6.302-1 only one source available (to continue ongoing project , changing variables in the middle of the ongoing project may compromise results) no substitutions possible. THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION; QUOTATIONS ARE BEING REQUESTED, AND A WRITTEN SOLICITATION WILL NOT BE ISSUED. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC 2005-91, dated Nov 30, 2016. The associated North American Industry Classification System (NAICS) Code is 325199, which has a size standard of 1,500 employees. All responsible sources who feel they can meet these requirements shall submit an offer that will be considered by the Agency. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Offers must be submitted no later than 5:00 P.M. Eastern Time Friday, November 4, 2016 through the U.S. Postal Service or preferred carrier to NIH/NIAID/AMOB, 5601 Fishers Lane, Room 3B24, MSC 9822, Bethesda, MD, 20892 (Fedex 20852). Email and fax submissions are acceptable. Point of contact concerning this requirement is James Kish, who can be reached by phone at 240-669-5110, f 240-6270-3150, or e-mailed to kishj@niaid.nih.gov.